Search
Search Results
##search.searchResults.foundPlural##
-
THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
2677PDF: 837HTML: 14967Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 321 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
2275PDF: 616Suppl. Files: 285HTML: 176 -
-
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1702PDF: 733HTML: 234 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
1059PDF: 938Suppl. Files: 463HTML: 293 -
THALIDOMIDE AMELIORATES ERYTHROPOIESIS AND IRON HOMEOSTASIS IN TRANSFUSION-DEPENDENT β-THALASSEMIA Thalidomide ameliorates erythropoiesis and iron homeostasis
1420PDF: 1435PDF: 1020HTML: 214 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2431PDF: 1597HTML: 644 -
-
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1127PDF: 488HTML: 8182 -
MODULATING EFFECT OF THE ?158 G? (C?T) XMN-1 POLYMORPHISM IN INDIAN SICKLE CELL PATIENTS
1538PDF: 906HTML: 1436Table: 195 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1259PDF: 650HTML: 7734 -
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1206PDF: 951HTML: 461 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2180PDF: 1315Html: 301 -
How I treat acute and persistent sickle cell pain
1967PDF: 1123HTML: 490 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
988PDF: 540HTML: 728 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3156PDF: 977HTML: 3137flowcytometric result of peripheral blood sample: 185 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1905PDF: 1062HTML: 296 -
Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
2810PDF: 771HTML: 1279Blood Count trend before and during lenalidomide treatment: 174Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 198 -
High Prevalence of Antiphospholipid Antibodies in Children with Non-Transfusion Dependent Thalassemia and Possible Correlations with Microparticles Antiphospholipid Antibodies and Thalassemia in children
951PDF: 611HTML: 290 -
EXTREMELY OLD PATIENTS HOSPITALIZED IN INTERNAL MEDICINE: WHAT ABOUT THEIR ANEMIA? Anemia in the elderly
1625PDF: 513HTML: 243 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
2566PDF: 1209HTML: 11809 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1967PDF: 1178HTML: 275 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1135PDF: 500HTML: 243 -







